[Elephantiasic pretibial myxoedema: study of five cases].
Identifieur interne : 003787 ( PubMed/Curation ); précédent : 003786; suivant : 003788[Elephantiasic pretibial myxoedema: study of five cases].
Auteurs : S O Niang ; M. Diallo ; A. Kane ; T I Bocoum ; M T Dieng ; B. NdiayeSource :
- Dakar medical [ 0049-1101 ] ; 2007.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anti-inflammatoires (administration et posologie), Anti-inflammatoires (usage thérapeutique), Antithyroïdiens (administration et posologie), Antithyroïdiens (usage thérapeutique), Biopsie, Dermatoses de la jambe (), Dermatoses de la jambe (anatomopathologie), Dermatoses de la jambe (diagnostic), Facteurs temps, Femelle, Hormones corticosurrénaliennes (usage thérapeutique), Humains, Maladie de Basedow (), Maladie de Basedow (traitement médicamenteux), Myxoedème (), Myxoedème (anatomopathologie), Myxoedème (diagnostic), Mâle, Prednisone (administration et posologie), Prednisone (usage thérapeutique), Résultat thérapeutique, Éléphantiasis (), Éléphantiasis (traitement médicamenteux), Évolution de la maladie.
- MESH :
- administration et posologie : Anti-inflammatoires, Antithyroïdiens, Prednisone.
- anatomopathologie : Dermatoses de la jambe, Myxoedème.
- diagnostic : Dermatoses de la jambe, Myxoedème.
- traitement médicamenteux : Maladie de Basedow, Éléphantiasis.
- usage thérapeutique : Anti-inflammatoires, Antithyroïdiens, Hormones corticosurrénaliennes, Prednisone.
- Adolescent, Adulte, Adulte d'âge moyen, Biopsie, Dermatoses de la jambe, Facteurs temps, Femelle, Humains, Maladie de Basedow, Myxoedème, Mâle, Résultat thérapeutique, Éléphantiasis, Évolution de la maladie.
English descriptors
- KwdEn :
- Adolescent, Adrenal Cortex Hormones (therapeutic use), Adult, Anti-Inflammatory Agents (administration & dosage), Anti-Inflammatory Agents (therapeutic use), Antithyroid Agents (administration & dosage), Antithyroid Agents (therapeutic use), Biopsy, Disease Progression, Elephantiasis (complications), Elephantiasis (drug therapy), Female, Graves Disease (complications), Graves Disease (drug therapy), Humans, Leg Dermatoses (complications), Leg Dermatoses (diagnosis), Leg Dermatoses (pathology), Male, Middle Aged, Myxedema (complications), Myxedema (diagnosis), Myxedema (pathology), Prednisone (administration & dosage), Prednisone (therapeutic use), Time Factors, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Anti-Inflammatory Agents, Antithyroid Agents, Prednisone.
- chemical , therapeutic use : Adrenal Cortex Hormones, Anti-Inflammatory Agents, Antithyroid Agents, Prednisone.
- complications : Elephantiasis, Graves Disease, Leg Dermatoses, Myxedema.
- diagnosis : Leg Dermatoses, Myxedema.
- drug therapy : Elephantiasis, Graves Disease.
- pathology : Leg Dermatoses, Myxedema.
- Adolescent, Adult, Biopsy, Disease Progression, Female, Humans, Male, Middle Aged, Time Factors, Treatment Outcome.
Abstract
Elephantiasic myxoedema is very rare. We report 5 pretibial myxoedema cases observed in the Dermatological department of Le Dantec hospital in Dakar.
PubMed: 19102101
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003787
Links to Exploration step
pubmed:19102101Curation
No country items
S O Niang<affiliation><nlm:affiliation>Service de Dermatologie, CHU Le Dantec BP 3001, Dakar Sénégal. suzeoumou@yahoo.com</nlm:affiliation><wicri:noCountry code="subField">Dakar Sénégal</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Elephantiasic pretibial myxoedema: study of five cases].</title><author><name sortKey="Niang, S O" sort="Niang, S O" uniqKey="Niang S" first="S O" last="Niang">S O Niang</name><affiliation><nlm:affiliation>Service de Dermatologie, CHU Le Dantec BP 3001, Dakar Sénégal. suzeoumou@yahoo.com</nlm:affiliation><wicri:noCountry code="subField">Dakar Sénégal</wicri:noCountry></affiliation></author><author><name sortKey="Diallo, M" sort="Diallo, M" uniqKey="Diallo M" first="M" last="Diallo">M. Diallo</name></author><author><name sortKey="Kane, A" sort="Kane, A" uniqKey="Kane A" first="A" last="Kane">A. Kane</name></author><author><name sortKey="Bocoum, T I" sort="Bocoum, T I" uniqKey="Bocoum T" first="T I" last="Bocoum">T I Bocoum</name></author><author><name sortKey="Dieng, M T" sort="Dieng, M T" uniqKey="Dieng M" first="M T" last="Dieng">M T Dieng</name></author><author><name sortKey="Ndiaye, B" sort="Ndiaye, B" uniqKey="Ndiaye B" first="B" last="Ndiaye">B. Ndiaye</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:19102101</idno><idno type="pmid">19102101</idno><idno type="wicri:Area/PubMed/Corpus">003787</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003787</idno><idno type="wicri:Area/PubMed/Curation">003787</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003787</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Elephantiasic pretibial myxoedema: study of five cases].</title><author><name sortKey="Niang, S O" sort="Niang, S O" uniqKey="Niang S" first="S O" last="Niang">S O Niang</name><affiliation><nlm:affiliation>Service de Dermatologie, CHU Le Dantec BP 3001, Dakar Sénégal. suzeoumou@yahoo.com</nlm:affiliation><wicri:noCountry code="subField">Dakar Sénégal</wicri:noCountry></affiliation></author><author><name sortKey="Diallo, M" sort="Diallo, M" uniqKey="Diallo M" first="M" last="Diallo">M. Diallo</name></author><author><name sortKey="Kane, A" sort="Kane, A" uniqKey="Kane A" first="A" last="Kane">A. Kane</name></author><author><name sortKey="Bocoum, T I" sort="Bocoum, T I" uniqKey="Bocoum T" first="T I" last="Bocoum">T I Bocoum</name></author><author><name sortKey="Dieng, M T" sort="Dieng, M T" uniqKey="Dieng M" first="M T" last="Dieng">M T Dieng</name></author><author><name sortKey="Ndiaye, B" sort="Ndiaye, B" uniqKey="Ndiaye B" first="B" last="Ndiaye">B. Ndiaye</name></author></analytic><series><title level="j">Dakar medical</title><idno type="ISSN">0049-1101</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adrenal Cortex Hormones (therapeutic use)</term><term>Adult</term><term>Anti-Inflammatory Agents (administration & dosage)</term><term>Anti-Inflammatory Agents (therapeutic use)</term><term>Antithyroid Agents (administration & dosage)</term><term>Antithyroid Agents (therapeutic use)</term><term>Biopsy</term><term>Disease Progression</term><term>Elephantiasis (complications)</term><term>Elephantiasis (drug therapy)</term><term>Female</term><term>Graves Disease (complications)</term><term>Graves Disease (drug therapy)</term><term>Humans</term><term>Leg Dermatoses (complications)</term><term>Leg Dermatoses (diagnosis)</term><term>Leg Dermatoses (pathology)</term><term>Male</term><term>Middle Aged</term><term>Myxedema (complications)</term><term>Myxedema (diagnosis)</term><term>Myxedema (pathology)</term><term>Prednisone (administration & dosage)</term><term>Prednisone (therapeutic use)</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anti-inflammatoires (administration et posologie)</term><term>Anti-inflammatoires (usage thérapeutique)</term><term>Antithyroïdiens (administration et posologie)</term><term>Antithyroïdiens (usage thérapeutique)</term><term>Biopsie</term><term>Dermatoses de la jambe ()</term><term>Dermatoses de la jambe (anatomopathologie)</term><term>Dermatoses de la jambe (diagnostic)</term><term>Facteurs temps</term><term>Femelle</term><term>Hormones corticosurrénaliennes (usage thérapeutique)</term><term>Humains</term><term>Maladie de Basedow ()</term><term>Maladie de Basedow (traitement médicamenteux)</term><term>Myxoedème ()</term><term>Myxoedème (anatomopathologie)</term><term>Myxoedème (diagnostic)</term><term>Mâle</term><term>Prednisone (administration et posologie)</term><term>Prednisone (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Éléphantiasis ()</term><term>Éléphantiasis (traitement médicamenteux)</term><term>Évolution de la maladie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Antithyroid Agents</term><term>Prednisone</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Anti-Inflammatory Agents</term><term>Antithyroid Agents</term><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-inflammatoires</term><term>Antithyroïdiens</term><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Dermatoses de la jambe</term><term>Myxoedème</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis</term><term>Graves Disease</term><term>Leg Dermatoses</term><term>Myxedema</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Leg Dermatoses</term><term>Myxedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Dermatoses de la jambe</term><term>Myxoedème</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis</term><term>Graves Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Leg Dermatoses</term><term>Myxedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladie de Basedow</term><term>Éléphantiasis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term><term>Antithyroïdiens</term><term>Hormones corticosurrénaliennes</term><term>Prednisone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Biopsy</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie</term><term>Dermatoses de la jambe</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Maladie de Basedow</term><term>Myxoedème</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Éléphantiasis</term><term>Évolution de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Elephantiasic myxoedema is very rare. We report 5 pretibial myxoedema cases observed in the Dermatological department of Le Dantec hospital in Dakar.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19102101</PMID><DateCreated><Year>2008</Year><Month>12</Month><Day>23</Day></DateCreated><DateCompleted><Year>2009</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0049-1101</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>2</Issue><PubDate><Year>2007</Year></PubDate></JournalIssue><Title>Dakar medical</Title><ISOAbbreviation>Dakar Med</ISOAbbreviation></Journal><ArticleTitle>[Elephantiasic pretibial myxoedema: study of five cases].</ArticleTitle><Pagination><MedlinePgn>95-9</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Elephantiasic myxoedema is very rare. We report 5 pretibial myxoedema cases observed in the Dermatological department of Le Dantec hospital in Dakar.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Our 5 cases were 3 women (age: 52, 45 and 18 years) and 2 men (age: 54 and 32 years).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All the cases were enormous, multinodular pachydermic, bilateral, elephantiasis in the low leg and associated to Graves 'disease. The duration was 4 month to 12 year. In 3 cases there was a Diamond syndrome which is a severe form. The cutaneous lesions were not influenced by medical treatment of thyroid disease. Systemic steroids achieved improvement of the elephantiasis in 1 case.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Elephantiasis is a very unusual presentation of pretibial myxoedema and its occurrence doesn't depend to the intensity of thyrotoxicosis and its evolution. However in our cases, it was a severity indicator factor, like Diamond syndrome. Local and systemic steroids give very rarely improvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niang</LastName><ForeName>S O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Service de Dermatologie, CHU Le Dantec BP 3001, Dakar Sénégal. suzeoumou@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kane</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bocoum</LastName><ForeName>T I</ForeName><Initials>TI</Initials></Author><Author ValidYN="Y"><LastName>Dieng</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Ndiaye</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Myxoedème prétibial eléphantiasique: une etude de cinq cas.</VernacularTitle></Article><MedlineJournalInfo><Country>Senegal</Country><MedlineTA>Dakar Med</MedlineTA><NlmUniqueID>7907630</NlmUniqueID><ISSNLinking>0049-1101</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013956">Antithyroid Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013956" MajorTopicYN="N">Antithyroid Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004604" MajorTopicYN="N">Elephantiasis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006111" MajorTopicYN="N">Graves Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007868" MajorTopicYN="N">Leg Dermatoses</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009230" MajorTopicYN="N">Myxedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19102101</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003787 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003787 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:19102101
|texte= [Elephantiasic pretibial myxoedema: study of five cases].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19102101" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |